Brainsway (BWAY) Cash from Investing Activities (2018 - 2026)
Brainsway (BWAY) reported Cash from Investing Activities of -$9.3 million for Q1 2026, down 374.42% on a YoY basis from $3.4 million in Q1 2025, and down 802.9% quarter-over-quarter from -$1.0 million in Q4 2025.
Brainsway (BWAY) Cash from Investing Activities (2018 - 2026) Analysis & Trends
Brainsway has reported Cash from Investing Activities for 9 years, with the latest figure at -$9.3 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities fell 374.42% year-over-year to -$9.3 million; the trailing twelve-month figure through Mar 2026 stood at -$24.9 million (down 185.54% YoY), and the FY2025 full-year result was -$17.5 million, down 157.62% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$9.3 million, down from -$1.0 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $40.8 million in Q2 2022, with the low at -$35.5 million in Q4 2023.
- Historically, Cash from Investing Activities has averaged $485294.1 across 5 years, with a median of -$710000.0 in 2024.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities sank 8403.51% — and 2024, when it jumped 2363.27%.
- Brainsway's Cash from Investing Activities stood at $427000.0 in 2022, then slumped by 8403.51% to -$35.5 million in 2023, then jumped by 94.8% to -$1.8 million in 2024, then soared by 43.95% to -$1.0 million in 2025, then sank by 802.9% to -$9.3 million in 2026.
- The last three Cash from Investing Activities figures came in at -$9.3 million (Q1 2026), -$1.0 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -92.80 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -2.50 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | -298.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Brainsway | 877.80 | -68.84 Mn | 11.68 Mn | -9.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.33 Mn |
| Mar 31, 2026 | -9.33 Mn |
| Dec 31, 2025 | -1.03 Mn |
| Dec 31, 2025 | -1.03 Mn |
| Sep 30, 2025 | 1.37 Mn |
| Sep 30, 2025 | 1.37 Mn |
| Jun 30, 2025 | -15.86 Mn |
| Jun 30, 2025 | -15.86 Mn |
| Mar 31, 2025 | -1.97 Mn |
| Mar 31, 2025 | -1.97 Mn |
| Dec 31, 2024 | -1.84 Mn |
| Dec 31, 2024 | -1.84 Mn |
| Sep 30, 2024 | -1.33 Mn |
| Sep 30, 2024 | -1.33 Mn |
| Jun 30, 2024 | 34.20 Mn |
| Jun 30, 2024 | 34.20 Mn |
| Mar 31, 2024 | -710,000.00 |
| Mar 31, 2024 | -710,000.00 |
| Dec 31, 2023 | -35.46 Mn |
| Dec 31, 2023 | -35.46 Mn |